Resmed Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€261.85
Performance (%)
-8.30%
Price
09.04.26
€194.95
Summary
This prediction is currently active. With a performance of -8.30%, the BUY prediction for Resmed Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 0.309% | 0.309% |
| iShares Core DAX® | 3,07 % | 0,49 % |
| iShares Nasdaq 100 | 2,88 % | 0,08 % |
| iShares Nikkei 225® | 5,98 % | 3,03 % |
| iShares S&P 500 | 2,23 % | 0,05 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat